share_log

德琪醫藥-B:自願公告 ATG-010(塞利尼索片)新藥上市申請通過香港衛生署批准用於治療復發性及/ 或難治性多發性骨髓瘤

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE HONG KONG DEPARTMENT OF HEALTH FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

香港交易所 ·  Jul 16, 2023 19:52
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more